Rapport Therapeutics, Inc.

RAPP·NASDAQ·$39.71Share Price as of 11/2·$1BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/10/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report10/30/26 8-KCurrent report10/20/26 8-KCurrent report08/05/26 8-KCurrent report06/10/26 8-KCurrent report05/07/26

Prospectuses and Registrations

424B5Prospectus supplement10/30/26 424B5Prospectus supplement10/30/26 FWPFree writing prospectus10/28/26 FWPFree writing prospectus10/28/26 FWPFree writing prospectus10/28/26

Proxies

DEF 14ADefinitive proxy04/23/26 DEFA14AAdditional proxy materials04/23/26 DEF 14ADefinitive proxy04/24/25 DEFA14AAdditional proxy materials04/24/25

Ownership

Form 4Insider transaction10/30/26 Form 4Insider transaction10/23/26 Form 4Insider transaction10/23/26 Form 4Insider transaction10/22/26 Form 4Insider transaction10/22/26

Other

305B2305B210/29/26 ARSAnnual report to shareholders04/23/26 EFFECTRequest for effectiveness07/09/25 EFFECTRequest for effectiveness07/09/25 CORRESPCorrespondence with the SEC07/07/25